Updated cutaneous T-cell lymphoma TNMB staging criteria fail to identify patients with Sézary syndrome with low blood burden

2.

Kim

YH

,

Liu

HL

,

Mraz-Gernhard

S

,

Varghese

A

,

Hoppe

RT

.

Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression

.

Arch Dermatol

.

2003

;

139

(

7

):

857

-

866

.

3.

Willemze

R

,

Jaffe

ES

,

Burg

G

, et al.

WHO-EORTC classification for cutaneous lymphomas

.

Blood

.

2005

;

105

(

10

):

3768

-

3785

.

4.

Mangold

AR

,

Thompson

AK

,

Davis

MD

, et al.

Early clinical manifestations of Sézary syndrome: a multicenter retrospective cohort study

.

J Am Acad Dermatol

.

2017

;

77

(

4

):

719

-

727

.

5.

Park

J

,

Daniels

J

,

Wartewig

T

, et al.

Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity

.

Blood

.

2021

;

138

(

14

):

1225

-

1236

.

6.

Olsen

E

,

Vonderheid

E

,

Pimpinelli

N

, et al.

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

.

Blood

.

2007

;

110

(

6

):

1713

-

1722

.

7.

Scarisbrick

JJ

,

Hodak

E

,

Bagot

M

, et al.

Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force

.

Eur J Cancer

.

2018

;

93

:

47

-

56

.

8.

Olsen

EA

,

Whittaker

S

,

Willemze

R

, et al.

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

.

Blood

.

2022

;

140

(

5

):

419

-

437

.

9.

National Comprehensive Cancer Network

.

Primary Cutaneous Lymphomas (Version 1.2024)

. Accessed 9 February 2023. https://www.nccn.org/professionals/physician_gls/pdf/primary_cutaneous.pdf.

10.

Vonderheid

EC

,

Bernengo

MG

.

The Sézary syndrome: hematologic criteria

.

Hematol Oncol Clin North Am

.

2003

;

17

(

6

):

1367

-

1389

.